These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 36135837)

  • 1. Novel Vaccine Strategies and Factors to Consider in Addressing Health Disparities of HPV Infection and Cervical Cancer Development among Native American Women.
    Morales CG; Jimenez NR; Herbst-Kralovetz MM; Lee NR
    Med Sci (Basel); 2022 Sep; 10(3):. PubMed ID: 36135837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expert recommendations on human papillomavirus vaccine immunization strategies in China].
    Zhang XX; Wang W; Song YF; Zhang ZN; Yu WZ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2022 Sep; 56(9):1165-1174. PubMed ID: 36207876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Social expectations and government incentives in Malaysia's COVID-19 vaccine uptake.
    Abdul Aziz NI; Flanders S; Nungsari M
    PLoS One; 2022; 17(9):e0275010. PubMed ID: 36156604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistent disparities of cervical cancer among American Indians/Alaska natives: Are we maximizing prevention tools?
    Bruegl AS; Emerson J; Tirumala K
    Gynecol Oncol; 2023 Jan; 168():56-61. PubMed ID: 36399813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Markowitz LE; Dunne EF; Saraiya M; Lawson HW; Chesson H; Unger ER; ;
    MMWR Recomm Rep; 2007 Mar; 56(RR-2):1-24. PubMed ID: 17380109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophylaxis of cervical cancer and related cervical disease: a review of the cost-effectiveness of vaccination against oncogenic HPV types.
    Armstrong EP
    J Manag Care Pharm; 2010 Apr; 16(3):217-30. PubMed ID: 20331326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneously characterizing the comparative economics of routine female adolescent nonavalent human papillomavirus (HPV) vaccination and assortativity of sexual mixing in Hong Kong Chinese: a modeling analysis.
    Choi HCW; Jit M; Leung GM; Tsui KL; Wu JT
    BMC Med; 2018 Aug; 16(1):127. PubMed ID: 30115065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Racial and Ethnic Group Knowledge, Perceptions and Behaviors about Human Papillomavirus, Human Papillomavirus Vaccination, and Cervical Cancer among Adolescent Females.
    Bond SM; Cartmell KB; Lopez CM; Ford ME; Brandt HM; Gore EI; Zapka JG; Alberg AJ
    J Pediatr Adolesc Gynecol; 2016 Oct; 29(5):429-435. PubMed ID: 26915922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Designing Inclusive HPV Cancer Vaccines and Increasing Uptake among Native Americans-A Cultural Perspective Review.
    Bordeaux SJ; Baca AW; Begay RL; Gachupin FC; Caporaso JG; Herbst-Kralovetz MM; Lee NR
    Curr Oncol; 2021 Sep; 28(5):3705-3716. PubMed ID: 34590604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cervical Cancer: Preventable Deaths Among American Indian/Alaska Native Communities.
    Buck DiSilvestro J; Ulmer KK; Hedges M; Kardonsky K; Bruegl AS
    Obstet Gynecol Clin North Am; 2024 Mar; 51(1):125-141. PubMed ID: 38267123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women.
    Muñoz N; Kjaer SK; Sigurdsson K; Iversen OE; Hernandez-Avila M; Wheeler CM; Perez G; Brown DR; Koutsky LA; Tay EH; Garcia PJ; Ault KA; Garland SM; Leodolter S; Olsson SE; Tang GW; Ferris DG; Paavonen J; Steben M; Bosch FX; Dillner J; Huh WK; Joura EA; Kurman RJ; Majewski S; Myers ER; Villa LL; Taddeo FJ; Roberts C; Tadesse A; Bryan JT; Lupinacci LC; Giacoletti KE; Sings HL; James MK; Hesley TM; Barr E; Haupt RM
    J Natl Cancer Inst; 2010 Mar; 102(5):325-39. PubMed ID: 20139221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modelling the population-level impact of vaccination on the transmission of human papillomavirus type 16 in Australia.
    Regan DG; Philp DJ; Hocking JS; Law MG
    Sex Health; 2007 Sep; 4(3):147-63. PubMed ID: 17931528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Update of HPV-associated female genital cancers in the United States, 1999-2004.
    Watson M; Saraiya M; Wu X
    J Womens Health (Larchmt); 2009 Nov; 18(11):1731-8. PubMed ID: 19951205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of different human papillomavirus (HPV) vaccine types and dose schedules for prevention of HPV-related disease in females and males.
    Bergman H; Buckley BS; Villanueva G; Petkovic J; Garritty C; Lutje V; Riveros-Balta AX; Low N; Henschke N
    Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31755549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of Guillain-Barré Syndrome Among Older Adults Receiving Influenza Vaccine in Taiwan.
    Yen CC; Wei KC; Wang WH; Huang YT; Chang YC
    JAMA Netw Open; 2022 Sep; 5(9):e2232571. PubMed ID: 36129709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors.
    Arbyn M; Xu L; Simoens C; Martin-Hirsch PP
    Cochrane Database Syst Rev; 2018 May; 5(5):CD009069. PubMed ID: 29740819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Impact of COVID-19 and Vaccine on the Human Nervous System.
    Chen F; Cao P; Liu H; Cai D
    Neuroendocrinology; 2022; 112(11):1046-1057. PubMed ID: 35316815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing real world vaccine effectiveness: A review of Scotland's approach to monitoring human papillomavirus (HPV) vaccine impact on HPV infection and cervical disease.
    Cameron RL; Palmer TJ; Cuschieri K; Kavanagh K; Roy K
    Vaccine; 2024 Aug; 42(21):126177. PubMed ID: 39128198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity and safety of human papillomavirus-16/18 AS04-adjuvanted cervical cancer vaccine coadministered with combined diphtheria-tetanus-acellular pertussis-inactivated poliovirus vaccine to girls and young women.
    Garcia-Sicilia J; Schwarz TF; Carmona A; Peters K; Malkin JE; Tran PM; Behre U; Iturbe EB; Catteau G; Thomas F; Dobbelaere K; Descamps D; Dubin G;
    J Adolesc Health; 2010 Feb; 46(2):142-51. PubMed ID: 20113920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing the epidemiological impact on cervical cancer of switching from 4-valent to 9-valent HPV vaccine within a gender-neutral vaccination programme in Switzerland.
    Kind AB; Pavelyev A; Kothari S; El Mouaddin N; Schmidt A; Morais E; Guggisberg P; Lienert F
    BMC Public Health; 2020 May; 20(1):671. PubMed ID: 32398057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.